Fluoguide ASFRA Fluoguide Stock Report

FluoGuide A/S is a clinical stage biotechnology company, which engages in the development of drugs used for the improvement of surgical outcomes by making cancer fluorescent. The firm is a provider of solutions for maximizing surgical outcome through intelligent targeting. FluoGuide develops surgical solutions, which expected to reduce Cancer pain for the patient and increases the possibility of recovering as well as reducing costs for the health care system. The Company’s main product, FG001, is designed using FluoGuide’s uPAR technology platform to improve surgical precision by illuminating cancer cells intraoperatively. FluoGuide explores FG001 in three other severe cancer indications, namely lung, head & neck, meningioma and low grade glioma.